Saturday, February 27, 2021 |
Baltimore
46°
Cloudy
FOLLOW US:

Sheppard Pratt to renovate part of Towson campus for psychedelics research center

February 17, 2021

Local psychiatric hospital Sheppard Pratt is partnering with a fast-growing mental health care company to build out a center dedicated to research of psychedelic drugs. COMPASS Pathways plc (Nasdaq: CMPS), a United Kingdom-based company developing psychedelic mental health therapies, is establishing its first Centre of Excellence in collaboration with the Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.